Decision Diagnostics Corp (DECN)

[holdmfoldm]

is that the same sales that they cleared in 2012 ?



Throughout 2012 in anticipation of the introduction of Genstrip, which received clearance from U.S. FDA on November 30, 2012, we have evaluated our brand-name distribution model, a model that provides streams of revenue but extremely low profit margins, and over the course of the last 15 months we have phased out sales of those brand name products that have been a backbone of our current distribution business but provide low profit margins, if any at all, and will, in the future, compete directly with our Shasta Genstrip. Phasing out these products lowered our order intake by approximately $12,750,000 in

from the 2012 10K
FY2012 .http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=9225698

I won't ask about all the bad debt from the 12-17 Partner Customers

this is why investors are asking for fillings to be timely Iam ok with no PR's if they never did another one I would be ok with it
just File the required reports on time ,

now just what really is in that K ?